Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN CAPITAL DEFICIENCY

v2.4.0.8
CONSOLIDATED STATEMENTS OF CHANGES IN CAPITAL DEFICIENCY (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Beginning balance, Value $ (3,580,325) $ (2,769,125)
Proceeds from sale of common stock, value 950,000 650,000
Shares issued for anti dilution protection, value     
Warrant issued with sale of common stock (456,501)  
Shares issued to consultants, value 975,700  
Shares issued for litigation settlements, value 3,545,483  
Shares issued upon cashless exercise of warrants, value 82,813 6,503,402
Cancellation of founder's shares, value     
Shares issued upon conversion of convertible notes, value 3,173,934  
Shares issued for extinguishment of debt, value 5,404,615  
Warrants issued with sale of preferred stock 2,141,003  
Beneficial Conversion Feature of preferred stock 4,136,003  
Shares issued upon conversion of convertible preferred stock, value 1,358,997  
Deemed dividend on preferred stock (4,136,003)  
Net loss for year (19,621,901) (7,964,602)
Ending balance, Value (6,026,182) (3,580,325)
Common Stock
   
Beginning balance, Shares 63,142,969 55,181,166
Beginning balance, Value 63,143 55,181
Proceeds from sale of common stock, shares 3,800,000 1,755,000
Proceeds from sale of common stock, value 3,800 1,755
Shares issued for anti dilution protection, shares 2,518,356  
Shares issued for anti dilution protection, value 2,518  
Shares issued to consultants, shares 2,142,204  
Shares issued to consultants, value 2,142  
Shares issued for litigation settlements, shares 5,186,986  
Shares issued for litigation settlements, value 5,187  
Shares issued upon cashless exercise of warrants, shares 29,069 12,856,803
Shares issued upon cashless exercise of warrants, value 29 12,857
Cancellation of founder's shares, shares   (6,650,000)
Cancellation of founder's shares, value   (6,650)
Shares issued upon conversion of convertible notes, shares 22,317,714  
Shares issued upon conversion of convertible notes, value 22,318  
Shares issued for extinguishment of debt, shares 7,801,381  
Shares issued for extinguishment of debt, value 7,802  
Shares issued upon conversion of convertible preferred stock, shares 7,000,000  
Shares issued upon conversion of convertible preferred stock, value 7,000  
Ending balance, Shares 113,938,679 63,142,969
Ending balance, Value 113,939 63,143
Additional Paid-In Capital
   
Beginning balance, Value 10,484,611 3,339,171
Proceeds from sale of common stock, value 946,200 648,245
Shares issued for anti dilution protection, value (2,518)  
Warrant issued with sale of common stock (456,501)  
Shares issued to consultants, value 973,558  
Shares issued for litigation settlements, value 3,540,296  
Shares issued upon cashless exercise of warrants, value 82,784 6,490,545
Cancellation of founder's shares, value   6,650
Shares issued upon conversion of convertible notes, value 3,151,616  
Shares issued for extinguishment of debt, value 5,396,813  
Warrants issued with sale of preferred stock 2,141,003  
Beneficial Conversion Feature of preferred stock 4,136,003  
Shares issued upon conversion of convertible preferred stock, value 1,351,997  
Ending balance, Value 27,609,859 10,484,611
Shareholder's Deficit
   
Beginning balance, Value (14,128,079) (6,163,477)
Deemed dividend on preferred stock (4,136,003)  
Net loss for year (19,621,901) (7,964,602)
Ending balance, Value $ (33,749,980) $ (14,128,079)